PNET 3/7/2015. GI and Pancreatic NETs. The Postgraduate Course in Breast and Endocrine Surgery. Decision Tree. GI and Pancreatic NETs.

Similar documents
ORIGINAL ARTICLE. Identification of Unknown Primary Tumors in Patients With Neuroendocrine Liver Metastases

NET und NEC. Endoscopic and oncologic therapy

ENDOLUMINAL APPROACH FOR THE MANAGEMENT OF GASTROINTESTINAL CARCINOID

NEUROENDOCRINE CARCINOID TUMORS PANCREATIC NEUROENDOCRINE TUMORS

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors

Diagnosing and monitoring NET

Oberndofer 1907 Illeal Serotonin Secreting Tumor Carcinoid (Karzinoide)

Imaging of Neuroendocrine Metastases

Surgical Therapy of GEP-NET: An Overview

NeuroEndocrine Tumors Diagnostic and therapeutic challenges: introduction

Carcinoid Tumors: The Beginning and End. Surgical Oncology Update 2011 Chris Baliski MD, FRCS BC Cancer Agency, CSI October 21, 2011

Neuroendocrine Tumors: Just the Basics. George Fisher, MD PhD

TRACTAMENT ONCOLÒGIC DELS TUMORS NEUROENDOCRINS METASTÀSICS

Surgical Management of Neuroendocrine Tumors of the Gut. Richard Hodin MD Professor of Surgery Massachusetts General Hospital Harvard Medical School

Update on Surgical Management of NETs

Systemic Therapy for Gastroenteropancreatic (GEP) Neuroendocrine Tumors and Lung Carcinoid

Imaging Pancreatic Neuroendocrine Tumors (PNETs): CT, MRI, EUS, Nuclear

Rare GI Malignancies

FRANKLY SPEAKING ABOUT CANCER: NEUROENDOCRINE & CARCINOID TUMORS (NETS)

5/17/2013. Pancreatic Cancer. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Case presentation. Differential diagnosis

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

Cutting Edge Treatment of Neuroendocrine Tumors

An Overview of NETS. Richard R.P. Warner M.D

Debulking of Extensive Neuroendocrine Liver Metastases

Cutting Edge Treatment of Neuroendocrine Tumors

NEUROENDOCRINE TUMORS

Neuroendocrine tumors (NETs) of unknown primary: is early surgical exploration and aggressive debulking justifiable?

Imaging Pancreatic Neuroendocrine Tumors (PNETs): CT, MRI, EUS, Nuclear

MEDICAL MANAGEMENT OF METASTATIC GEP-NET

NET εντέρου Τι νεότερο/ Νέες μελέτες. Μαντώ Νικολαΐδη παθολόγος-ογκολόγος ΜΗΤΕΡΑ

SCOPE TODAYS SESSION. Case 1: Case 2. Basic Theory Stuff: Heavy Stuff. Basic Questions. Basic Questions

Surgery for NET Challenges and specific aspects

3/28/2012. Periampullary Tumors. Postgraduate Course in General Surgery CASE 1: CASE 1: Overview. Eric K. Nakakura Ko Olina, HI

Principles of diagnosis, work-up and therapy The Gastroenterologist s role

Pancreatic neuroendocrine cancer with liver metastases and multiple peritoneal metastases: report of one case

Kentaro Tominaga, Kenya Kamimura, Junji Yokoyama and Shuji Terai

Disclosure of Relevant Financial Relationships

An Unexpected Cause of Hypoglycemia

Neuroendocrine Tumours If you don t suspect it you can t detect it! Dr JWS Devar HPB Surgeon University of Witwatersrand E-AHPBA CHBAH & WDGMC

Neuroendocrine Tumors

Gastrointestinal Carcinoid Tumor Early Detection, Diagnosis, and Staging

Type 2 gastric neuroendocrine tumor: report of one case

Intraoperative staging of GIT cancer using Intraoperative Ultrasound

Neuro-endocrine and pancreatic non-adenocarcinomas. Marc Engelbrecht, AMC, Amsterdam

GEP NEN. Personalised approach. Curative and Palliative Surgery. ESMO Preceptorship Programme Neuroendocrine Neoplasms Lugano April 2018

SIRT in the Management of Metastatic Neuroendocrine Tumors

Case Scenario 1. Discharge Summary

Treatment algorithm Neuroendocrine tumours. Gregory Kaltsas Endocrine Unit, Department of Pathophysiology, University of Athens, Greece

Management of Pancreatic Islet Cell Tumors

Clinical Management of Obscure- Overt Gastrointestinal Bleeding. Presented by Dr. 張瀚文

OPTIMISING OUTCOMES IN GASTROINTESTINAL NEUROENDOCRINE TUMOURS

What s New for 8 th Edition

Diagnosis abnormal morphology and /or abnormal biochemistry

GI CARCINOID Dr Mussawar Iqbal Consultant Oncologist Hull and East Yorkshire Hospitals NHS Trust

Commonly Encountered Neuro-Endocrine Tumors of the Gut

Management of an Appendiceal Mass - Approach to acute presentation of appendiceal neoplasms

Evaluation and Management of Neuroendocrine Tumors

Small cell neuroendocrine carcinoma icd 10

Color Codes Pathology and Genetics Medicine and Clinical Pathology Surgery Imaging

SURGERY OF NETS. Iakovos N Nomikos MD FACS. Director and Chairman, Department of Surgery METAXA Memorial Cancer Hospital Piraeus Greece

Radiology Pathology Conference

Case Presentation. Marianne Ellen Pavel. Charité University Medicine Berlin. ESMO Preceptorship on GI Neuroendocrine Tumors

Neuroendocrine Tumors

Grade 2 Ileum NET with liver and bone metastasis

Cross-sectional Imaging of Neuroendocrine Tumors of the Gastrointestinal Tract

OUTLINE OUTLINE 25/04/2018. Massimo Milione MD, PhD. General Features and Classifications. Ki67 role?

EXOCRINE: 93% Acinar Cells Duct Cells. ENDOCRINE: 5% Alpha Cells Beta Cells Delta Cells Others

Review of Gastrointestinal Carcinoid Tumors: Latest Therapies

Community Case. Saeed Awan R5

Objectives. Terminology 03/11/2013. Pitfalls in the diagnosis of Gastroenteropancreatic Neuroendocrine Tumors. Pathology Update 2013

Nuevas alternativas en el manejo de TNE avanzados

Neuroendocrine Tumor of Unknown Primary Accompanied with Stomach Adenocarcinoma

HEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options:

CEA (CARCINOEMBRYONIC ANTIGEN)

Carcinoembryonic Antigen

Hot of the press. Γρηγόριος Καλτσάς MD FRCP Καθηγητής Παθολογίας Ενδοκρινολογίας ΕΚΠΑ

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Imaging in gastric cancer

A LEADER IN ADVANCED ENDOSCOPY AND HEPATOBILIARY SURGERY

Strategies in the Management of Neuroendocrine Tumors. Dr. Jean Maroun Dr. Elena Tsvetkova

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

Interventional therapy for rectal neuroendocrine tumor with liver metastases: report of one case

EUS FNA NEUROENDOCRINE TUMORS. A. Ginès Endocopy Unit Hospital Cínic. Barcelona (Spain)

Lu 177-Dotatate (Lutathera) Therapy Information

Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012

2015: Year in Review Results of Recent Trials

Patient underwent hemicolectomy: 7 x 4.5 cm intusscepted segment of ileum in colon - mucosal

Gastrinoma: Medical Management. Haley Gallup

Learning. A part of your guide to Neuroendocrine Tumours (NETs)

CRITICAL ANALYSIS OF NEN GUIDELINES. G Pentheroudakis Associate Professsor of Oncology Medical School, University of Ioannina Chair, ESMO Guidelines

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

53 year old Female with Hypoglycemia. Colleen Flynn, MD April 5, 2012

Afternoon Session Cases

Moderators: Steven Fern, DO Sreenivas Jonnalagada, MD

The Role of Ultrasound in the Assessment of Inflammatory Bowel Disease

WHAT TO EXPECT IN 2015? - Renuka Iyer, MD Associate Professor of Medicine, University at Buffalo Associate Professor of Oncology, Roswell Park Cancer

Collecting Cancer Data: GIST/NET 1/9/14

Transcription:

GI and Pancreatic NETs The Postgraduate Course in Breast and Endocrine Surgery Disclosures Ipsen NET Advisory Board Marines Memorial Club and Hotel San Francisco, CA Eric K Nakakura San Francisco, CA March 6, 2015 Treatment of GI and Pancreatic Neuroendocrine Tumors NET Decision Tree Poorly differentiated (high grade) carcinoid PNET Paraganglioma/pheochromocytoma Neuroendocrine tumors (NETs) Welldifferentiated Platinumbased chemotx GI and Pancreatic NETs Histologic classification Differentiation Grade Mitotic Count Welldifferentiated Poorly differentiated Low (G1) Intermed (G2) High (G3) < 2 per 10 HPF 2-20 per 10 HPF > 20 per 10 HPF Ki-67 index (%) 2 3-20 Traditional Classification Carcinoid, islet cell, pancreatic neuroendocrine tumor Carcinoid, atypical carcinoid, Islet cell, pancreatic neuroendocrine tumor > 20 Small cell carcinoma Large cell neuroendocrine carcinoma ENETS, WHO Classification Neuroendocrine tumor, grade 1 Neuroendocrine tumor, grade 2 Neuroendocrine carcinoma, grade 3, small cell Neuroendocrine carcinoma, grade 3, large cell ENETS, European Neuroendocrine Tumor Society; WHO, World Health Organization; HPF, high-power fields 1

GI and Pancreatic Neuroendocrine tumors (NETs) Diverse diseases Insulinoma CASE 1 Laparoscopic enucleation of insulinoma Gastrinoma Small intestine NET (carcinoid) Nonfunctioning pancreatic NET (NF-PNET) Others Pancreas Specimen CASE 2 Multifocal NETs (N = 18) in ileum (carcinoid) CASE 3 Duodenal gastrinoma Duodenum Specimen 2

CASE 4 CASE 5 Whipple procedure for NF-PNET Total pancreatectomy for NF-PNET (12 cm) GI and Pancreatic Neuroendocrine tumors (NETs) Overview Focus on a very confusing issue in NETs It s not so confusing after all History and experience have shone us the light Seeing is believing Eric K Nakakura San Francisco, CA March 6, 2015 Neuroendocrine Tumors of Unknown Primary: Is the Primary Tumor Site Really Not Known? 3

GI and Pancreatic Neuroendocrine tumors (NETs) If you remember only two things NETs of unrecognized primary site are typically hiding in the ileum What does unknown primary mean? NETs of the ileum are often multifocal must palpate What does unknown primary mean? The location where the NET originated is not known Well-differentiated NET liver metastases Where did the tumor originate? 4

What does unknown primary mean? The location where the NET originated is not known Does finding the primary tumor matter? Possible primary sites: Small intestine (ileum, jejunum, duodenum) Pancreas Colon/rectum Bronchopulmonary Stomach Small intestine (ileum) NET Reasons for finding the primary tumor Symptoms Abdominal pain, weight loss Intestinal ischemia Asymptomatic Resect the primary as part of surgery to remove all gross disease Prevent bowel obstruction Prevent ischemia Improve outcome? Hellman et al World J Surg 2002 Boudreaux et al Ann Surg 2005 Givi et al Surgery 2006 5

Small intestine (ileum) NET Intestinal ischemia Small intestine (ileum) NET Intestinal obstruction Small intestine (ileum) NET Intestinal ischemia and obstruction Reasons for finding the primary tumor Treatment increasingly depends on site Everolimus, sunitinib for pancreatic NETs Octreotide for well differentiated midgut NETs Lanreotide for well-differentiated NF GI and pancreatic NETs Systemic chemotherapy for pancreatic NETs Participation in clinical trials Bergsland and Nakakura JAMA Surg 2014 6

What tests should be done to find it? What tests should be done to find it? Currently, there is no consensus on what minimum tests should be done before the primary site is considered unknown What tests should be done to find it? CT? MRI? OctreoScan? 68 Ga-DOTA-TATE or 68 Ga-DOTA-NOC PET-CT Upper/lower endoscopy? Endoscopic ultrasound? Enteroclysis? Capsule endoscopy? Double-balloon enteroscopy? Gene expression profiling? UCSF study Study design: Pathology database (1993-2008) Setting: UCSF Patients: 123 patients with NET liver metastases Outcomes: 1) Detection of primary tumor preop 2) Laparoscopic or open surgery to find and remove an unknown primary tumor Wang et al Arch Surg 2010 7

UCSF study Where is the primary site likely to be? Despite extensive evaluation, 138% had occult primary tumors Wang et al Arch Surg 2010 Siegfried Oberndorfer Gastrointestinal NETs Epidemiology (1876-1944) 1907: Pathological Institute of Geneva 1) multiple tumors in submucosa of ileum 2) slow growth 3) borders sharply circumscribed 4) (do not metastasize) Karzinoide: carcinoma-like 1929: He recognized potential to metastasize Modlin et al Hum Path 2004 Carcinoid site (1950-1971) (1973-1999) (no islet cell) n = 2425 n = 6996 % % Stomach 25 7 Small intestine 25 44 Appendix 48 7 Colon 8 13 Rectum 17 24 Modlin et al Cancer 2003 8

UCSF study results Multicenter results Primary site found in 13/15 patients (87%) by surgery All primary tumors in small intestine (12 ileum, 1 jejunum) Primary tumors small (14 cm) and often multifocal (54%) Careful palpation of small intestine is essential Wang et al Arch Surg 2010 ~ 84% success in finding primary Bergsland and Nakakura JAMA Surg 2014 Karnovsky Memorial Lecture Laparoscopic identification of tumor in ileum An Odyssey in the Land of Small Tumors Small intestine NETs Most (193/209; 92%) arise from ileum Multifocal (46/183; 25%) Primary tumors small, deep mucosal site of origin Nature of spread First invades muscle layer serosa mesentery (outward spread) Nature of obstruction Fibroblastic reaction in mesentery buckling of bowel wall kinking of bowel wall (like an accordian) Wang et al Arch Surg 2010 Moertel CG J Clin Oncol 1987 9

Laparoscopic identification of tumor in ileum Laparoscopic identification of tumor in ileum with Meckel s diverticulum Laparoscopic identification of tumor in ileum with regional adenopathy Multifocal primary tumors (N = 11) in ileum 10

Multifocal primary tumors (N = 11) in ileum Multifocal primary tumors (N = 11) in ileum Multifocal primary tumors (N = 11) in ileum (#2) Multifocal primary tumors (N = 11) in ileum (#2) 11

Finding the Primary Tumor What tests should be done to find it? CT scan: chest, abdomen/pelvis (multiphase, thin slice) Potentially seen on colonoscopy Somatostatin receptor scintigraphy (OctreoScan) Urine 24-h 5-HIAA Upper and lower endoscopy Immunohistochemical markers (TTF-1, CDX2, PAX8, Islet 1) Careful review by multidisciplinary team terminal ileum NET Finding the Primary Tumor Potentially seen on colonoscopy Take home points For most patients with WD-NETs and unknown primary the primary site is most likely in the ileum If surgery planned, appropriate preoperative tests should be done Many other tests (enteroclysis, capsule endoscopy, double-balloon enteroscopy, and endoscopic ultrasound) unnecessary since will not affect patient care and only delay treatment terminal ileum NET Must carefully palpate small intestine because ileum NETs are frequently multifocal 12

Patient example A 60-year-old man Patient example Fall 2008: abdominal pain Evaluated at a local hospital Bilobar liver masses Core needle biopsy: CgA +, Syn + Well-differentiated NET Unknown primary site Patient example A 60-year-old man with NET liver metastases and unknown primary Fall 2008: Started Sandostatin Patient informed his disease was inoperable UCSF for second opinion by multidisciplinary GI oncology group Winter 2008: Laparoscopic identification and resection of ileum primary tumor Wang et al Arch Surg 2010 13

Patient example A 60-year-old man with NET liver metastases and unknown primary Patient example Fall 2008: Started Sandostatin Winter 2008: Primary found and removed Fall 2009: Carcinoid syndrome Liver metastases stable Winter 2009: Right hepatectomy and microwave ablation of two left lobe tumors Carcinoid syndrome resolved Patient example A 60-year-old man with NET liver metastases and unknown primary Fall 2008: Started Sandostatin Winter 2008: Primary found and removed NETs of Unrecognized Primary NET(s) arising from the ileum Winter 2009: Resection/ablation of liver mets Dec 2014: No evidence of disease 14

15